Learn more

LEK TOVARNA FARMACEVTSKIH

Overview
  • Total Patents
    844
About

LEK TOVARNA FARMACEVTSKIH has a total of 844 patent applications. Its first patent ever was published in 1970. It filed its patents most often in Yugoslavia (Serbia and Montenegro), United States and Slovenia. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are LEK FARMAS JUTIKLZ D D, REDDYS LAB LTD DR and SEARLE LLC.

Patent filings per year

Chart showing LEK TOVARNA FARMACEVTSKIHs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Pflaum Zlatko 59
#2 Capuder Egidij 56
#3 Jenko Branko 40
#4 Zmitek Janko 40
#5 Kofler Bojan 39
#6 Rucman Rudolf 38
#7 Langof Igor 36
#8 Kerc Janez 36
#9 Kovacic Mateja 31
#10 Milivojevic Dusan 30

Latest patents

Publication Filing date Title
GB0523539D0 New use of organic compounds
SI21221A Quickly decomposable tablets
SI21233A High purity crystalline hydrate forms of amlodipine benzensulphonate, methods of their preparation and usage
EP1492878A1 Process for the preparation of a desired erythropoietin glyco-isoform profile
SI21137A Derivatives of azaphenyl-alanine
WO03055475A1 Controlled release pharmaceutical formulation containing venlafaxine
SI21102A Process for isolation of biologically active granulocyte colony stimulating factor
SI20875A Crystal form of omeprazole
SI20848A Pharmaceutical formulation containing atorvastatin calcium
SI20814A Preparation of amorphous atorvastatin
SI20720A New pharmaceutical preparation in the form of cellulose capsules applicable to derivatives of benzimidazole
SI20411A Watersoluble powders for peroral solution and their use
SI20425A Preparation of amorphous atorvastatin
CZ2001137A3 Process for obtaining HMG-CoA reductase inhibitors of high purity
SI20305A Pravastatin sodium salt crystals
HU0103015A2 Pharmaceutical suspension formulation comprising amoxycillin, clavulanic acid and cellulose
SI20246A Use of compound n-(2-(2-(1-adamanthancarboxamido)-ethoxy)-acetyl)-l-alanyl-d- isoglutamine in veterinary medicine
SI20244A Melt granulation
SI20150A Directly compressible matrix for controlled release of the daily dose of clarytomicyne
SI20159A New process for the removal of the silyloxy protective group from 4-silyoxy tetrahydro-pyran-2-ons